[#item_full_content] Revenue grew 8% year-over-year to CAD 45 million, led by international medical cannabis, now over half of total revenue. Gross margin improved to 35% in Q4, and the company ended the year with CAD 10.8 million cash and no material debt.Based on MediPharm Labs Corp. [LABS] Q4 2025 Audio Transcript —…
Read More
LABS: International medical cannabis drove 8% revenue growth and margin gains, with strong liquidity